Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy

Abstract Aims Recognition of transthyretin amyloid cardiomyopathy is increasing due to advances in cardiac imaging and diagnostic strategies, but questions remain regarding disease frequency and characteristics. We examined the prevalence and characteristics of transthyretin amyloid cardiomyopathy i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pablo Garcia‐Pavia, Thibaud Damy, Nicolas Piriou, Roberto Barriales‐Villa, Francesco Cappelli, Catherine Bahus, Carmen Munteanu, Denis Keohane, Pablo Mallaina, Perry Elliott, the TTRACK investigators
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	ESC Heart Failure
Subjects:	Cardiac amyloidosis Epidemiology Hypertrophy Prevalence Transthyretin amyloid cardiomyopathy
Online Access:	https://doi.org/10.1002/ehf2.14971
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review
by: Katrine Bay, et al.
Published: (2022-06-01)

Transthyretin amyloid cardiomyopathy in France: A cross-sectional multi-centre study (333 patients)
by: Thibaud Damy, et al.
Published: (2024-01-01)

AMYLOID CARDIOMYOPATHY: DIAGNOSIS AND TREATMENT
by: Elena S Eniseeva
Published: (2023-12-01)

Sustained Ventricular Tachycardia as the first presentation of transthyretin amyloid cardiomyopathy
by: Hugo R. Ramos, et al.
Published: (2024-12-01)

A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
by: Naoya Nakashima, et al.
Published: (2022-06-01)

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy
by: Rosa Lauppe, et al.
Published: (2022-06-01)

Hereditary transthyretin amyloidosis incidentally diagnosed by video-associated lung surgery for lung cancer: A case report
by: Katsuhiro Itogawa, et al.
Published: (2025-01-01)

A Comparative Study of the Electroneurographic Findings in Amyloidotic Polyneuropathy in Patients with Light-Chain Amyloidosis and Glu54Gln Transthyretin Amyloidosis
by: Mirela Drăghici, et al.
Published: (2024-12-01)

Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program
by: Kunal Bhatt, et al.
Published: (2024-12-01)

Associations of Left Atrial Volume Index to Left Ventricular Ejection Fraction Ratio with Clinical Outcomes in Transthyretin Cardiac Amyloidosis
by: Yeabsra K. Aleligne, et al.
Published: (2024-11-01)

Neuroprotective effect against amyloidogenic transthyretin aggregates - Induced cytotoxicity on human neuroblastoma cell by phenolic-rich Centella asiatica extract
by: Fredrick Nwude Eze, et al.
Published: (2024-10-01)

HEREDITARY TRANSTERETIN AMYLOIDOSIS. CLINICAL CASE
by: Elena Yuryevna Bagadaeva
Published: (2023-09-01)

The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement
by: Chafic Karam, et al.
Published: (2024-11-01)

Specific therapeutic options for transthyretin amyloidosis
by: Zoltán Pozsonyi
Published: (2024-12-01)

Cationic Surface Charge Engineering of Recombinant Transthyretin Remarkably Increases the Inhibitory Potency Against Amyloid β-Protein Fibrillogenesis
by: Xiaoding Lin, et al.
Published: (2024-10-01)

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01)

Symptoms of Hereditary Transthyretin Amyloidosis: The Patient and Physician Perspective
by: Michael Lane, et al.
Published: (2024-09-01)

Improving Health Equity Through Standardization and Selective Expansion of Genetic Testing in Transthyretin Amyloidosis
by: Nishant R. Shah, et al.
Published: (2024-12-01)

Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
by: Fumi Oike, et al.
Published: (2022-06-01)

A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
by: Juan David López-Ponce de León, et al.
Published: (2025-02-01)

Hereditary transthyretin amyloid cardiomyopathy
by: Yiliang Zheng, et al.
Published: (2023-01-01)

Exosome-Derived microRNAs in Hypertrophic Cardiomyopathy
by: Brian Xiangzhi Wang
Published: (2024-12-01)

Cardiac Amyloidosis Masquerading as Hypertrophic Obstructive Cardiomyopathy: Co-existence or Coincidence?
by: Madhu Shukla, et al.
Published: (2024-07-01)

Experience of Hereditary Amyloidosis with Rare Variant in Ecuador: Case Reports
by: Diana Elizabeth Luzuriaga Carpio, et al.
Published: (2024-10-01)

Global longitudinal strain in pre-symptomatic patients with mutation for transthyretin amyloidosis
by: Grazia Canciello, et al.
Published: (2024-12-01)

Importance of fourth heart sound and preserved left atrial function in wild‐type transthyretin amyloidosis
by: Yuri Ochi, et al.
Published: (2024-12-01)

Myocardial work assessment to improve baseline risk stratification in patients with transthyretin amyloidosis
by: Ana Moya, et al.
Published: (2024-12-01)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
by: J Gustav Smith, et al.
Published: (2021-12-01)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Sarala Raj Murthi, et al.
Published: (2025-01-01)

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis
by: Mileydis Alonso, et al.
Published: (2024-12-01)

First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia
by: Omar Ahmad, et al.
Published: (2024-12-01)

Clinical differential factors in patients with hereditary transthyretin amyloidosis with Val142Ile and Ser43Asn mutations
by: Sandra Milena Castellar-Leones, et al.
Published: (2024-12-01)

Transthyretin-Related Familial Amyloidosis Polyneuropathy with Spinal Cord Damage: A Case Report
by: Liu H, et al.
Published: (2025-01-01)

The differential diagnostic value of left ventricular segmental myocardial strain in cardiac amyloidosis and non-obstructive hypertrophic cardiomyopathy
by: Yang LIU, et al.
Published: (2024-12-01)

Algorithm for Investigation of Fabry Disease in Cardiomyopathies
by: Sandra Marques e Silva, et al.
Published: (2024-10-01)

Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm
by: Jessica Ammon, et al.
Published: (2024-11-01)

Phenotype and prognostic factors in geriatric and non‐geriatric patients with transthyretin cardiomyopathy
by: Eugenia Volpentesta, et al.
Published: (2024-12-01)

Low transthyretin is associated with the poor prognosis of colorectal cancer
by: Zhe Zhang, et al.
Published: (2025-02-01)

Case Report: Avoiding misdiagnosis in amyloidosis—navigating transthyretin genopositivity and monoclonal gammopathy in a patient with advanced heart failure and spinal stenosis
by: Xia Wu, et al.
Published: (2024-12-01)

The myocardial function index (MFI): An integrated measure of cardiac function in AL-cardiomyopathy
by: Nadia Akhiyat, et al.
Published: (2024-12-01)